Full Text
EE713 Cost-Effectiveness of Adjuvant Nivolumab for Patients With Stage III and IV Melanoma Who Have Undergone Complete Resection in Austria

Abstract

Authors

M Voit G Eichhober E Walter CE Boehler

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×